Status:

COMPLETED

Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans

Lead Sponsor:

Tammie L. S. Benzinger, MD, PhD

Conditions:

Alzheimer Disease

Eligibility:

All Genders

65+ years

Brief Summary

The purpose of this research study is to evaluate a new radioactive compound used in positron emission tomography (PET) scans in identifying tau tangles (a certain protein that might be associated wit...

Eligibility Criteria

Inclusion

  • Male or female participants, at least 65 years of age.
  • Participant is willing to undergo a lumbar puncture (LP) or has previously undergone LP. LP will be conducted under IRB ID 201109100 (PI: Anne Fagan).
  • Participant is able and willing to undergo positron emission tomography (PET) and magnetic resonance imaging (MRI) of the brain.
  • Pre-menopausal women must have a negative urine pregnancy test within 24 hours preceding T807 drug administration.

Exclusion

  • Has any condition that, in the Investigator's opinion, could increase risk to the participant, limit the participant's ability to tolerate the experimental procedures, or interfere with the collection/analysis of the data (for example, participants with severe chronic back pain might not be able to lie still during the scanning procedures).
  • Is deemed likely unable to perform the imaging procedures for any reason.
  • Has a history of Torsades de Pointes or is taking medications known to prolong or may prolong QT interval (refer to study's list of restricted medications).
  • Has known hypersensitivity to T807 or any of its excipients.
  • Contraindications to PET, PET-CT or MR (e.g. electronic medical devices, inability to lie still for long periods) that make it unsafe for the individual to participate.
  • Severe claustrophobia.
  • Currently pregnant or breast-feeding. -

Key Trial Info

Start Date :

May 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 19 2021

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT03287765

Start Date

May 1 2016

End Date

July 19 2021

Last Update

May 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110